Canada’s Regulators Hold J&J Vaccine Over Emergent Link

The step was taken after Health Canada learned that an active ingredient was made in a Baltimore plant with contamination problems.

source https://www.nytimes.com/live/2021/04/30/world/covid-vaccine-coronavirus-cases/canada-johnson-johnson-vaccine

एक टिप्पणी भेजें